KRAS signaling is also a shared component in signaling pathways regulating pluripotency of stem cells, microRNAs in cancer and oxytocin signaling pathway (hsa04550, hsa05206, and hsa04921, respectively), suggesting its central role in obesity and cancer pathology. Here, OXT is linked to obesity due to melanocortin 4 receptor deficiency.